Seong Young Kwon

High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era

Deok‐Hwan Yang, Gyeong‐Won Lee, Sung-Nam Lim et al. · Leukemia Research · 2016 · 65 citations

Medicine, Hematology, Oncology +15

Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board

Minseok Kim, Ha-Young Park, Bo‐Gun Kho et al. · Translational Lung Cancer Research · 2020 · 59 citations · Full text

Medicine, Oncology, Surgery +14

Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity

Jahae Kim, Sang‐Geon Cho, Sae‐Ryung Kang et al. · Journal of Nuclear Cardiology · 2019 · 56 citations

Medicine, Oncology, Radiology +14

Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

Sae‐Ryung Kang, Ho‐Chun Song, Byung Hyun Byun et al. · Nuclear Medicine and Molecular Imaging · 2013 · 54 citations · Full text

Medicine, Oncology, Medical Oncology +15

Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer

Su Woong Yoo, Jahae Kim, Ari Chong et al. · Nuclear Medicine and Molecular Imaging · 2012 · 53 citations · Full text

Medicine, Nuclear Medicine, Oncology +14